Back
Bolsa Mexicana de Valores SAB de CV Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
39
BOMXF
Bolsa Mexicana de Valores SAB de CV
Last Price:
$1.93
Seasonality Move:
-8.31%
Buy
61
ALNY
Alnylam Pharmaceuticals
Last Price:
$290.61
Seasonality Move:
3.3%
Sell
39
Bolsa Mexicana de Valores SAB de CV (BOMXF)
is a Sell
Is Bolsa Mexicana de Valores SAB de CV a Buy, Sell or Hold?
-
The current Bolsa Mexicana de Valores SAB de CV [BOMXF] share price is $1.82. The Score for BOMXF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
BOMXF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BOMXF Stock Price Chart
What is Bolsa Mexicana de Valores SAB de CV's stock price today?
-
The Bolsa Mexicana de Valores SAB de CV share price today is $1.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BOMXF is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $283.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BOMXF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 51.5 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 1.89) | Sell |
Bollinger Bands (100): | (1.55 - 1.77) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 68.89 | Buy |
Chaikin Money Flow: | 1798941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.98 - 259.48) | Buy |
Bollinger Bands (100): | (240.26 - 271.94) | Buy |
BOMXF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.87 | Sell |
20-day SMA: | 1.84 | Sell |
50-day SMA: | 1.7 | Buy |
200-day SMA: | 1.66 | Buy |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 1.83 | Sell |
50-day EMA: | 1.75 | Buy |
200-day EMA: | 1.72 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 251.71 | Buy |
20-day SMA: | 247.77 | Buy |
50-day SMA: | 256.39 | Buy |
200-day SMA: | 250.79 | Buy |
8-day EMA: | 256.23 | Buy |
20-day EMA: | 252.43 | Buy |
50-day EMA: | 253.95 | Buy |
200-day EMA: | 242.96 | Buy |
Bolsa Mexicana de Valores SAB de CV Earnings Growth & BOMXF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.
Bolsa Mexicana de Valores SAB de CV Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |